Öz Geçmiş

EMRAH YURUK, M.D.

Associate Professor of Urology

Chairman, Department of Urology, BHT Clinic Istanbul TEMA Hospital

Istanbul, Turkey

Atakent M. 4th Street, 36, Istanbul

Work (0090850) 811 3400

e-mail: emrahyuruk@bhtclinic.com.tr

  1. EDUCATION

 

  1. EDUCATION

M.D.       Istanbul University, Cerrahpaşa School of Medicine, Istanbul, Turkey    2003

  1. MEDICAL LICENSURE AND CERTIFICATION
  • EAU Residents Education Program (EUREP), Prague, Czech Rep.                                   2009
  • Visiting Urologist, Dept. of Urology, Tulane University, New Orleans, USA            2013
  • Certificate in Laboratory Animal Science                                                               2014

EXPERIENCE

 

  1. PROFESSIONAL EXPERIENCE

  • Urologist, Babaeski State Hospital, Kirklareli                                            2010-2012
  • Urologist, KSS Training & Research Hospital, Istanbul                             2012-2012
  • Urologist, Bagcilar Training & Research Hospital, Istanbul                                  2012-2015
  • Associate Prof. of Urology, Bagcilar Hospital, Istanbul                             2015-2017
  • Chair, Dept. of Urology, Univ. of Health Sciences, Bagcilar Hosp                        2016-2020
  • Chair, Dept. of Urology, BHT Clinic Istanbul TEMA Hospital                 2020-

 

  1. FELLOWSHIP / RESIDENCY

  • General Surg. Residency, Taksim Training & Research Hospital, Istanbul            2003-2004
  • Urology Residency, Haseki Training & Research Hospital, Istanbul         2005-2010

III. APPOINTMENTS IN SOCIETIES AND REVIEW BOARDS

 

  1. COMMITTEES

  • Member of Turkish Association of Urology Academy Endourology and Urooncology Group
  • Secretary General of TUA Board Exam Committee
  • EULIS Associate Member
  • EULIS Webpage Coordinator
  • Associate Editor of Turkish Journal of Urology
  • University of Health Sciences Assessment and Evaluation Committee Vice President

 

  1. REVIEWERSHIPS

  • Reviewer, Journal of ‘Journal of Endourology’
  • Reviewer, Journal of ‘World Journal of Urology’
  • Reviewer, Journal of ‘International Journal of Urology’
  • Reviewer, Journal of ‘Urologic Oncology – Seminars and Original Investigations’
  • Reviewer, Journal of ‘Asian Journal of Andrology’
  • Reviewer, Journal of ‘Urology Journal’
  • Reviewer, Journal of ‘BMJ Case Reports’
  • Reviewer, Journal of ‘Turkish Journal of Medical Sciences’
  • Reviewer, Journal of ‘Turkish Journal of Urology’
  • Reviewer, Journal of ‘Journal of Epidemiology and Global Health’
  1. AFFILIATIONS

  1. Turkish Association of Urology
  2. National Endourology Society
  3. European Association of Urology
  4. Endourology Society
  5. Societe Internationale d’Urologie
  6. Eurasian Uro-oncology Association

PUBLICATIONS IN REFEREED INTERNATIONAL JOURNALS

 

  1. Gul A, Yuruk E, Serefoglu EC. Frequency of nocturnal emissions and masturbation habits among virgin male religious teenagers. Rev Int Androl. 2018 Dec 31. pii: S1698-031X(18)30081-5. doi: 10.1016/j.androl.2018.08.002
  2. Yürük E. No-cable and smartphone/tablet: A functional laparoscopic training box “Fu Lap T-Box”. Turk J Urol. 2018 Sep;44(5):432. doi:10.5152/tud.2018.030918
  3. Bolat MS, Yürük E, Çınar Ö, Akdeniz E, Altunrende F, Özkuvancı Ü, Tomak L, Kadıoğlu A, Müslümanoğlu AY. The prevalence of Burnout Syndrome among Turkish Urologists: Results of a Nationwide Survey. Turk J Urol. 2018 Nov 21;45(6):449-455. doi: 10.5152/tud.2018.34202.
  4. Temiz MZ, Colakerol A, Ertas K, Tuken M, Yuruk E. Fiberoptic versus Digital: A Comparison of Durability and Cost Effectiveness of the Two Flexible Ureteroscopes. Urol Int. 2019;102(2):181-186. doi: 10.1159/000494385.
  5. Kandıralı E, Temiz MZ, Çolakerol A, Yürük E, Semerciöz A, Müslümanoğlu AY. Does the prostate volume always effect cancer detection rate in prostate biopsy? Additional role of prostate-specific antigen levels: A retrospective analysis of 2079 patients. Turk J Urol. 2018 Mar 16;45(2):103-107. doi: 10.5152/tud.2018.66909
  6. Aykan S, Temiz MZ, Yilmaz M, Ulus I, Yuruk E, Muslumanoglu AY. Association between male accesory gland infections and prostate cancer in Turkish men: A case-control study. Andrologia. 2018 Sep;50(7):e13038. doi: 10.1111/and.13038.
  7. Temiz MZ, Yuruk E, Ertas K, Zengi O, Semercioz A. Effects of statin treatment with atorvastatin on urolithiasis-associated urinary metabolic risk factors: an experimental study. Int Urol Nephrol. 2018 Feb;50(2):231-236. doi: 10.1007/s11255-017-1762-0.
  8. Tuken M, Temiz MZ, Yuruk E, Kaptanagasi AO, Basak K, Narter F, Muslumanoglu AY, Sarica K. The role of an herbal agent in treatment for Escherichia coli induced bacterial cyctitis in rats. Arch Ital Urol Androl. 2017 Jun 30;89(2):134-138. doi: 10.4081/aiua.2017.2.134.
  9. Sarica K, Yuruk E. Re: The Economic Implications of a Reusable Flexible Digital Ureteroscope: A Cost-Benefit Analysis. Eur Urol. 2017 Oct;72(4):652-653. doi: 10.1016/j.eururo.2017.05.047.
  10. Yuruk E, Tuken M, Colakerol A, Serefoglu EC. The awareness of patients with non – muscle invasive bladder cancer regarding the importance of smoking cessation and their access to smoking cessation programs. Int Braz J Urol. 2017 Jul-Aug;43(4):607-614. doi: 10.1590/S1677-5538.IBJU.2016.0014.
  11. Yürük E, Saitz TR, Gönültaş S, Şerefoğlu EC, Müslümanoğlu AY. Neutrophil-to-lymphocyte ratio is elevated in recurringnonmuscle invasive bladder cancer. Turk J Med Sci. 2017 Feb 27;47(1):234-239. doi: 10.3906/sag-1509-73.
  12. Yuruk E, Tuken M, Gonultas S, Colakerol A, Cakir OO, Binbay M, Sarica K, Muslumanoglu AY. Retrograde intrarenal surgery in the management of pediatric cystine stones. J Pediatr Urol. 2017 Oct;13(5):487.e1-487.e5. doi:10.1016/j.jpurol.2017.01.015.
  13. Sarica K, Yuruk E. What should we do with residual fragments. Arch Esp Urol. 2017 Jan;70(1):245-250. Review. PubMed PMID: 28221159.
  14. Yuruk E, Pastuszak AW, Suggs JM 3rd, Colakerol A, Serefoglu EC. The association between seminal vesicle size and duration of abstinence from ejaculation. Andrologia. 2017 Sep;49(7). doi: 10.1111/and.12707.
  15. Yürük E, Yentur S, Çakır ÖO, Ertaş K, Şerefoğlu EC, Semerciöz A. Catheter dwell time and diameter affect the recurrence rates after internal urethrotomy. Turk J Urol. 2016 Sep;42(3):184-9. doi: 10.5152/tud.2016.90490.
  16. Binbay M, Yuruk E, Ucpinar B, Binbay Z, Colakerol A, Muslumanoglu AY. Laparoscopic Partial Nephrectomy for Renal-Cell Carcinoma During Pregnancy. J Endourol Case Rep. 2016 Feb 1;2(1):18-20. doi: 10.1089/cren.2015.0012.
  17. Yuruk E, Gureser G, Tuken M, Ertas K, Serefoglu EC. A novel dosimeter for measuring the amount of radiation exposure of surgeons during percutaneous nephrolithotomy: Instadose™. Cent European J Urol. 2016;69(2):198-203. doi:10.5173/ceju.2016.779.
  18. Yuruk E, Tuken M, Sulejman S, Colakerol A, Serefoglu EC, Sarica K, Muslumanoglu AY. Computerized tomography attenuation values can be used to differentiate hydronephrosis from pyonephrosis. World J Urol. 2017 Mar;35(3):437-442. doi: 10.1007/s00345-016-1888-1.
  19. Yuruk E, Tuken M, Sahin C, Kaptanagasi AO, Basak K, Aykan S, Muslumanoglu AY, Sarica K. The protective effects of an herbal agent tutukon on ethylene glycol and zinc disk induced urolithiasis model in a rat model. Urolithiasis. 2016 Nov;44(6):501-507.
  20. Yuruk E, Temiz MZ, Colakerol A, Muslumanoglu AY. Mucosal cuff length to penile length ratio may affect the risk of premature ejaculation in circumcised males. Int J Impot Res. 2016 Mar-Apr;28(2):54-6. doi: 10.1038/ijir.2015.34.
  21. Temiz MZ, Yuruk E, Aykan S, Tuken M, Kandirali E. Isolated Penile Fournier’s Gangrene Presenting with Glans Penis Involvement. J Coll Physicians Surg Pak. 2015 Oct;25 Suppl 2:S140-1. doi: 10.2015/JCPSP.S140141.
  22. Erbin A, Yürük E, Binbay M, Müslümanoğlu AY. Giant kidney stone: multi-session percutaneous nephrolithotomy with 12 accesses. Turk J Urol. 2015 Sep;41(3):155-8. doi: 10.5152/tud.2015.17992.
  23. Aykan S, Yuruk E, Tuken M, Temiz MZ, Ozsoy S. Rare but Lethal Disease of Childhood: Metastatic, Muscle Invasive Bladder Cancer. Pediatr Rep. 2015 Sep 28;7(3):5928. doi: 10.4081/pr.2015.5928.
  24. Yuruk E. Editorial Comment to Retrograde intrarenal surgery for urinary stone disease in patients with solitary kidney: A retrospective analysis of the efficacy and safety. Int J Urol. 2016 Jan;23(1):74. doi: 10.1111/iju.12990.
  25. Yürük E, Binbay M, Akman T, Özgör F, Berberoğlu Y, Müslümanoğlu AY. Previous shock-wave lithotripsy treatment does not impact the outcomes of flexible ureterorenoscopy. Turk J Urol. 2014 Dec;40(4):211-5. doi: 10.5152/tud.2014.83446.
  26. Huri E, Skolarikos A, Tatar İ, Binbay M, Sofikerim M, Yuruk E, Karakan T, Sargon M, Demiryurek D, Miano R, Bagcioglu M, Ezer M, Cracco CM, Scoffone CM. Simulation of RIRS in soft cadavers: a novel training model by the Cadaveric Research On Endourology Training (CRET) Study Group. World J Urol. 2016 May;34(5):741-6. doi: 10.1007/s00345-015-1676-3.
  27. Urolithiasis. 2016 Apr;44(2):109-15. doi: 10.1007/s00240-015-0813-1.
  28. Temiz MZ, Yuruk E, Teberik K, Kandirali E. Surgical Removal of an Unrecognized Tapestry Needle from the Urethra. Clin Pract. 2015 Jun 23;5(2):740. doi:10.4081/cp.2015.740.
  29. Temiz MZ, Yuruk E, Teberik K, Akbas BK, Piroglu MD, Oztorun HS, Kandirali E. Ischemic hepatitis after percutaneous nephrolitotomy: A case report. Int J Surg Case Rep. 2014;5(12):1258-60. doi: 10.1016/j.ijscr.2014.10.087.
  30. Yuruk E, Binbay M, Ozgor F, Erbin A, Berberoglu Y, Muslumanoglu AY. Flexible ureterorenoscopy is safe and efficient for the treatment of kidney stones in patients with chronic kidney disease. Urology. 2014 Dec;84(6):1279-84. doi:10.1016/j.urology.2014.07.038.
  31. Yuruk E, Binbay M, Ozgor F, Sekerel L, Berberoglu Y, Muslumanoglu AY. Comparison of shockwave lithotripsy and flexible ureteroscopy for the treatment of kidney stones in patients with a solitary kidney. J Endourol. 2015 Apr;29(4):463-7. doi: 10.1089/end.2014.0613.
  32. Yuruk E, Serefoglu EC. Re: Peyronie’s disease plaque calcification–prevalence, time to identification, and development of a new grading classification. J Sex Med. 2014 May;11(5):1351.
  33. Yuruk E, Cakir O, Binbay M. Re: Bhageria A, Nayak B, Seth A, Dogra PN, Kumar R. Pediatric percutaneous nephrolithotomy: Single-centre 10-year experience. J Pediatr Urol 2013;9:472-5. J Pediatr Urol. 2014 Feb;10(1):196-7. doi: 10.1016/j.jpurol.2013.08.016.
  34. Sari E, Tepeler A, Yuruk E, Resorlu B, Akman T, Binbay M, Armagan A, Unsal A, Muslumanoglu AY. Effect of the body mass index on outcomes of flexible ureterorenoscopy. Urolithiasis. 2013 Nov;41(6):499-504. doi: 10.1007/s00240-013-0590-7.
  35. Tepeler A, Binbay M, Akman T, Erbin A, Kezer C, Silay MS, Yuruk E, Kardas S, Akçay M, Armagan A, Muslumanoglu AY. Parenchymal thickness: does it have an impact on outcomes of percutaneous nephrolithotomy? Urol Int. 2013;90(4):405-10. doi:10.1159/000346336.
  36. Yazici O, Binbay M, Akman T, Kezer C, Ozgor F, Yuruk E, Berberoglu Y, Muslumanoglu AY. Is there a difference in percutaneous nephrolithotomy outcomes among various types of pelvicaliceal system? World J Urol. 2013 Oct;31(5):1267-72. doi:10.1007/s00345-012-0907-0.
  37. Perioperative prophylaxis for percutaneous nephrolithotomy: randomized study concerning the drug and dosage. J Endourol. 2012 Nov;26(11):1431-6. doi: 10.1089/end.2012.0242.
  38. Akman T, Binbay M, Kezer C, Yuruk E, Tekinarslan E, Ozgor F, Sari E, Aslan R, Berberoglu Y, Muslumanoglu AY. Factors affecting kidney function and stone recurrence rate after percutaneous nephrolithotomy for staghorn calculi: outcomes of a long-term follow up. J Urol. 2012 May;187(5):1656-61. doi: 10.1016/j.juro.2011.12.061.
  39. Binbay M, Yuruk E, Akman T, Sari E, Yazici O, Ugurlu IM, Berberoglu Y, Muslumanoglu AY. Updated epidemiologic study of urolithiasis in Turkey II: role of metabolic syndrome components on urolithiasis. Urol Res. 2012 Jun;40(3):247-52. doi: 10.1007/s00240-011-0447-x.
  40. Muslumanoglu AY, Yuruk E, Binbay M, Akman T. Transurethral resection of prostate with plasmakinetic energy: 100 months results of a prospective randomized trial. BJU Int. 2012 Aug;110(4):546-9. doi: 10.1111/j.1464-410X.2011.10770.x.
  41. Akman T, Binbay M, Aslan R, Yuruk E, Ozgor F, Tekinarslan E, Yazici O, Berberoglu Y, Muslumanoglu AY. Long-term outcomes of percutaneous nephrolithotomy in 177 patients with chronic kidney disease: a single center experience. J Urol. 2012 Jan;187(1):173-7. doi: 10.1016/j.juro.2011.09.038.
  42. Altunrende F, Tefekli A, Stein RJ, Autorino R, Yuruk E, Laydner H, Binbay M, Muslumanoglu AY. Clinically insignificant residual fragments after percutaneous nephrolithotomy: medium-term follow-up. J Endourol. 2011 Jun;25(6):941-5. doi: 10.1089/end.2010.0491.
  43. Akman T, Binbay M, Sari E, Yuruk E, Tepeler A, Akcay M, Muslumanoglu AY, Tefekli A. Factors affecting bleeding during percutaneous nephrolithotomy: single surgeon experience. J Endourol. 2011 Feb;25(2):327-33. doi: 10.1089/end.2010.0302.
  44. Muslumanoglu AY, Binbay M, Yuruk E, Akman T, Tepeler A, Esen T, Tefekli AH. Updated epidemiologic study of urolithiasis in Turkey. I: Changing characteristics of urolithiasis. Urol Res. 2011 Aug;39(4):309-14. doi: 10.1007/s00240-010-0346-6.
  45. Binbay M, Yuruk E, Akman T, Ozgor F, Seyrek M, Ozkuvanci U, Berberoglu Y, Muslumanoglu AY. Is there a difference in outcomes between digital and fiberoptic flexible ureterorenoscopy procedures? J Endourol. 2010 Dec;24(12):1929-34. doi: 10.1089/end.2010.0211.
  46. Akman T, Binbay M, Yuruk E, Sari E, Seyrek M, Kaba M, Berberoglu Y, Muslumanoglu AY. Tubeless procedure is most important factor in reducing length of hospitalization after percutaneous nephrolithotomy: results of univariable and multivariable models. Urology. 2011 Feb;77(2):299-304. doi: 10.1016/j.urology.2010.06.060.
  47. Akman T, Sari E, Binbay M, Yuruk E, Tepeler A, Kaba M, Muslumanoglu AY, Tefekli A. Comparison of outcomes after percutaneous nephrolithotomy of staghorn calculi in those with single and multiple accesses. J Endourol. 2010 Jun;24(6):955-60. doi: 10.1089/end.2009.0456.
  48. Yuruk E, Binbay M, Sari E, Akman T, Altinyay E, Baykal M, Muslumanoglu AY, Tefekli A. A prospective, randomized trial of management for asymptomatic lower pole calculi. J Urol. 2010 Apr;183(4):1424-8. doi: 10.1016/j.juro.2009.12.022.
  49. Tepeler A, Binbay M, Yuruk E, Sari E, Kaba M, Muslumanoglu AY, Tefekli A. Factors affecting the fluoroscopic screening time during percutaneous nephrolithotomy. J Endourol. 2009 Nov;23(11):1825-9. doi: 10.1089/end.2009.0256.
  50. Yuruk E, Tefekli A, Sari E, Karadag MA, Tepeler A, Binbay M, Muslumanoglu AY. Does previous extracorporeal shock wave lithotripsy affect the performance and outcome of percutaneous nephrolithotomy? J Urol. 2009 Feb;181(2):663-7. doi: 10.1016/j.juro.2008.10.016. Epub 2008 Dec 16. PubMed PMID: 19091339.

VII. INVITED SPEAKER

 

  • 7th Eurasian Urooncology Congress, 26-29 January 2017, Edirne, Turkey
  • 4th Meeting of The EAU Section of Urolithiasis, 5-7 October 2017, Vienna, Austria
  • 9th Iranian Endourology and Urolaparoscopy Congress, 22-24 November 2017, Tehran, Iran
  • 33rd Annual EAU Congress, 16-20 March 2018, Copenhagen, Denmark
  • 8th Eurasian Urooncology Congress, 28 June-1 July 2018, Tbilisi, Georgia
  • 38th Congress of the Societe Internationale d’Urologie, 4-7 October 2018, Seoul, South Korea
  • Turkish-Russian Urology Congress, 5-6 April 2019, St. Petersburg, Russia
  • 9th Eurasian Urooncology Congress, 16-18 October 2019, Athens, Greece
  • 11th Iranian Endourology and Urolaparoscopy Congress, 4-6 December 2019, Tehran, Iran
WhatsApp chat